Main Navigation

Quick Links

Recursion signs partnership that could net company billions


Recursion Pharmaceuticals Inc. has announced it has formed a drug-discovery collaboration with Swiss drug and diagnostics giant Roche AG, and its U.S. subsidiary Genentech, that is potentially worth several billion dollars to the Salt Lake City-based clinical-stage biotechnology company in the next 10 years. Recursion said it will work with the research and development units […]

Read More